C4XD — C4X Discovery Holdings Share News
0.000.00%
Last trade - 00:00- £20.75m
- £7.88m
- £1.71m
C4X Discovery - Half Year Results
C4X Discovery - Notice of Results
C4X Discovery - Result of AGM
C4X Discovery - MALT-1 Inhibitor Programme Update
C4X Discovery - Nick Ray Appointed as Chief Scientific Officer
C4X Discovery - Posting of 2022 Annual Report and Notice of AGM
UK's C4X Discovery slides on wider FY loss, revenue drop
Brief: C4x Discovery Says FY Revenue Of £2.7 Mln
C4X Discovery - Full Year Results
C4X Discovery - Notice of Final Results
UK's C4X Discovery climbs to 6-month high on licencing deal with AstraZeneca
Brief: C4x Discovery Signs Exclusive Global Licence Worth Up To $402 Million With Astrazeneca
UK's C4X Discovery signs $400 mln licensing deal with AstraZeneca
C4X Discovery - C4XD Agreement with AstraZeneca
AIM - AIM Notice - 04/11/2022
C4X Discovery - Exercise of Options, Issue of Equity and TVR
Brief: C4X Discovery Announces Research Collaboration With HitGen
C4X Discovery - C4XD and HitGen to collaborate in inflammation
C4X Discovery - Holding(s) in Company